Huntington Bancshares Incorporated (HBAN) Stock Analysis
Is HBAN a good investment?
Huntington Bancshares Incorporated (HBAN) has a Plutrex AI rating of 65.0/100 as of August 21, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: PEG ratio of 0.62 vs. industry average 1.298 — a 52.2% discount to peers — is the single most compelling valuation argument; combined with next-year forward EPS growth of 35.6% (vs. industry 25.8%), HBAN's growth is dramatically underpriced relative to regional bank peers, and the analyst consensus target of $20.26 implies 19.1% upside from $17.01. Main concern: Rising deposit costs (headline: 'Rising Deposit Costs Emerge As The Latest Key Worry For Huntington Bancorp') remain an active NIM compression threat — UNCHANGED from prior report — that directly undermines the 35.6% next-year EPS growth thesis; this is the single biggest near-term execution risk and has not been resolved by any metric movement.
Investment Summary
Huntington Bancshares (HBAN) at $17.01 remains a value/recovery play in regional banking with a compelling PEG ratio of 0.62 (vs. industry average 1.298 — a 52% discount), a P/E of 13.11x (11% below the industry average of 14.73x), and an analyst consensus target of $20.26 implying 19.1% upside. The core thesis is unchanged from the prior report: HBAN is in an earnings trough with trailing EPS growth of -7.2% YoY, but analysts project 35.6% next-year EPS growth and a 14.7% five-year EPS CAGR, driven by the company's stated 18-19% ROTCE target by 2027 (vs. current ROE of 9.0%). The stock has declined 4.3% from $17.77 to $17.01 since the prior report, modestly improving the margin of safety. Key concerns — rising deposit costs compressing NIM and below-peer ROE of 9.0% vs. industry 11.3% — remain unchanged. The Q2 2026 adjusted EPS of $0.39 (up $0.02 sequentially) provides incremental evidence of recovery, but the value-trap risk persists until demonstrated earnings power catches up to projections. Net assessment: Buy with medium conviction, improved entry opportunity at current levels.
Key Strengths
- PEG ratio of 0.62 vs. industry average 1.298 — a 52.2% discount to peers — is the single most compelling valuation argument; combined with next-year forward EPS growth of 35.6% (vs. industry 25.8%), HBAN's growth is dramatically underpriced relative to regional bank peers, and the analyst consensus target of $20.26 implies 19.1% upside from $17.01
- Q2 2026 adjusted EPS of $0.39 (up $0.02 sequentially) with revenue growth of 47.6% (vs. industry 19.8%) provides early evidence of the earnings recovery thesis materializing; inclusion in the August Graham Value All-Stars list (headline: 'Graham Value All-Stars (GVAS) Emit 12 Bright August Buys') corroborates the quantitative undervaluation signals from multiple independent frameworks
- P/B of 1.16x near tangible book value (~$14.65/share) provides meaningful downside protection; the company's stated 18-19% ROTCE target by 2027 (headline: 'Here's How Huntington Plans to Achieve Its 18-19% ROTCE Target by 2027') offers a specific, time-bound roadmap for ROE improvement from 9.0% to a level that would justify a materially higher stock price
Key Concerns
- Rising deposit costs (headline: 'Rising Deposit Costs Emerge As The Latest Key Worry For Huntington Bancorp') remain an active NIM compression threat — UNCHANGED from prior report — that directly undermines the 35.6% next-year EPS growth thesis; this is the single biggest near-term execution risk and has not been resolved by any metric movement
- ROE of 9.0% is 20.7% below the industry average of 11.3% and below the ~10% cost-of-equity threshold; combined with trailing EPS growth of -7.2% YoY, FCF of $0, and D/E of 0.57 (19.5% above industry average of 0.477), the value-trap risk is real — the bull case depends entirely on projected rather than demonstrated earnings power, and the stock's 4.3% decline since the prior report suggests the market is not yet rewarding the recovery thesis
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
HBAN's fundamentals present a classic recovery-play profile. Valuation is the standout: PEG of 0.62 (vs. industry 1.298) is the primary bull signal, indicating the market prices HBAN's growth at a 52% discount to peers. P/E of 13.11x is 11% below the industry average of 14.73x, and P/B of 1.16x provides near-book-value downside protection (estimated book ~$14.65/share). Profitability is the primary weakness: ROE of 9.0% is 20.7% below the industry average of 11.3% and below the ~10% cost-of-equity threshold for regional banks. Operating margin of 41.9% trails the industry average of 45.5% by 7.7%, and net margin of 15.7% lags peers at 18.5% by 15.1%. Free cash flow of $0 limits financial flexibility. Growth metrics are bifurcated: trailing EPS growth of -7.2% YoY is deeply negative vs. the industry's +131.7% recovery, but forward next-year EPS growth of 35.6% exceeds the industry average of 25.8% by 38%, and revenue growth of 47.6% dwarfs the industry's 19.8%. Total cash of $16.6 billion provides adequate liquidity. The 35.6% forward EPS growth vs. -7.2% trailing creates a credibility gap — the bull case requires the earnings recovery to materialize as projected. The 18-19% ROTCE target by 2027 (headline: 'Here's How Huntington Plans to Achieve Its 18-19% ROTCE Target by 2027') provides a specific roadmap but remains unproven.
News Sentiment
Huntington Bancshares is quietly building a case for a comeback — but investors are watching closely to see if the Ohio-based regional bank can actually deliver on its ambitious promises. The bank recently reported second-quarter 2026 earnings showing adjusted EPS of $0.39, up two cents from the prior quarter, suggesting the business is slowly healing after a rough stretch. That incremental improvement matters because Huntington has set a bold target: achieving an 18-19% return on tangible common equity by 2027, roughly double its current profitability level. The question on Wall Street is whether management can actually get there. The biggest obstacle? Rising deposit costs. As the headline 'Rising Deposit Costs Emerge As The Latest Key Worry For Huntington Bancorp' signals, banks across the industry are paying more to keep customer deposits, which squeezes the profit margin on loans — the lifeblood of any bank's earnings. For Huntington, which is already earning below-average returns compared to peers, this headwind couldn't come at a worse time. On the bright side, the stock earned a spot on the August Graham Value All-Stars list — a recognition that value-focused investors see the stock as genuinely cheap relative to its earnings potential. With shares trading near $17 and analysts targeting $20.26, the math suggests meaningful upside if Huntington can execute. For patient investors, this is a recovery story worth watching — but not without real risks.
Risk Assessment
Primary risk: NIM compression from rising deposit costs (headline: 'Rising Deposit Costs Emerge As The Latest Key Worry For Huntington Bancorp') could delay or derail the 35.6% next-year EPS growth projection, extending the earnings trough and validating the value-trap concern. Secondary risk: ROE of 9.0% remaining below cost of equity (~10%) means HBAN is technically destroying shareholder value at current profitability levels — if the 18-19% ROTCE target by 2027 slips, the re-rating thesis collapses. Tertiary risk: The stock has declined 4.3% since the prior report despite no material negative news, suggesting weak technical momentum and possible institutional distribution. Mitigation: Stop-loss at $15.25 (~1.04x estimated book value of ~$14.65) limits downside to approximately 9.6% from the $16.88 entry midpoint; at this level, the stock would trade at near-book, providing a hard fundamental floor. Position size of 3.0% limits portfolio impact. The 2.3:1 risk/reward ratio (19.4% upside to target_1 vs. 9.6% downside to stop) provides adequate compensation for the execution risk.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is HBAN a halal stock?
No, Huntington Bancshares Incorporated (HBAN) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for HBAN?
Huntington Bancshares Incorporated (HBAN) has a Plutrex AI rating of 65.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is HBAN a good investment?
According to Plutrex AI, HBAN has a Buy rating (65.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in HBAN?
US stocks like HBAN can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in HBAN?
Plutrex AI identifies the main risks for HBAN by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.